Captor Therapeutics Spolka Akcyjna (WSE: CTX)
Poland
· Delayed Price · Currency is PLN 76.40
+0.40 (0.53%)
Sep 27, 2024, 5:00 PM CET
CTX Market Cap
CTX has a market cap or net worth of 356.24 million as of September 30, 2024. Its market cap has decreased by -28.47% in one year.
Market Cap
356.24M
Enterprise Value
306.07M
Revenue
18.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
76.40
Market Cap Chart
Since April 19, 2021, CTX's market cap has decreased from 749.17M to 356.24M, a decrease of -52.45%. That is a compound annual growth rate of -19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 27, 2024 | 356.24M | -22.54% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 18.06B |
| NEUCA S.A. | 3.61B |
| Sopharma AD | 2.17B |
| Synektik Spólka Akcyjna | 1.59B |
| Celon Pharma S.A. | 1.49B |
| Ryvu Therapeutics S.A. | 1.26B |
| Voxel S.A. | 1.13B |
| Selvita S.A. | 1.04B |